nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Leflunomide—systemic scleroderma	0.0286	0.608	CbGbCtD
Bexarotene—CYP2C9—cardial valve—systemic scleroderma	0.0187	0.672	CbGeAlD
Bexarotene—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0103	0.218	CbGbCtD
Bexarotene—CYP3A4—Prednisone—systemic scleroderma	0.0082	0.174	CbGbCtD
Bexarotene—RXRG—tendon—systemic scleroderma	0.00279	0.1	CbGeAlD
Bexarotene—RXRB—tendon—systemic scleroderma	0.00262	0.0942	CbGeAlD
Bexarotene—RXRB—lung—systemic scleroderma	0.0023	0.0827	CbGeAlD
Bexarotene—CYP2C9—digestive system—systemic scleroderma	0.000808	0.0291	CbGeAlD
Bexarotene—CYP3A4—digestive system—systemic scleroderma	0.000616	0.0222	CbGeAlD
Bexarotene—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00039	0.000421	CcSEcCtD
Bexarotene—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00039	0.000421	CcSEcCtD
Bexarotene—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00042	CcSEcCtD
Bexarotene—Erectile dysfunction—Prednisone—systemic scleroderma	0.000388	0.00042	CcSEcCtD
Bexarotene—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000388	0.000419	CcSEcCtD
Bexarotene—Feeling abnormal—Leflunomide—systemic scleroderma	0.000387	0.000419	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000387	0.000418	CcSEcCtD
Bexarotene—Fatigue—Mycophenolic acid—systemic scleroderma	0.000387	0.000418	CcSEcCtD
Bexarotene—Mood swings—Methotrexate—systemic scleroderma	0.000386	0.000418	CcSEcCtD
Bexarotene—Nausea—Mometasone—systemic scleroderma	0.000386	0.000417	CcSEcCtD
Bexarotene—Anorexia—Lisinopril—systemic scleroderma	0.000385	0.000416	CcSEcCtD
Bexarotene—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000384	0.000415	CcSEcCtD
Bexarotene—Weight increased—Prednisone—systemic scleroderma	0.000384	0.000415	CcSEcCtD
Bexarotene—Ataxia—Methotrexate—systemic scleroderma	0.000383	0.000414	CcSEcCtD
Bexarotene—Pain—Mycophenolic acid—systemic scleroderma	0.000383	0.000414	CcSEcCtD
Bexarotene—Constipation—Mycophenolic acid—systemic scleroderma	0.000383	0.000414	CcSEcCtD
Bexarotene—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000383	0.000414	CcSEcCtD
Bexarotene—Weight decreased—Prednisone—systemic scleroderma	0.000382	0.000412	CcSEcCtD
Bexarotene—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000381	0.000412	CcSEcCtD
Bexarotene—Hyperglycaemia—Prednisone—systemic scleroderma	0.00038	0.000411	CcSEcCtD
Bexarotene—Cough—Mycophenolate mofetil—systemic scleroderma	0.000378	0.000409	CcSEcCtD
Bexarotene—Dizziness—Captopril—systemic scleroderma	0.000377	0.000408	CcSEcCtD
Bexarotene—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000377	0.000407	CcSEcCtD
Bexarotene—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000374	0.000405	CcSEcCtD
Bexarotene—Abdominal pain—Leflunomide—systemic scleroderma	0.000372	0.000402	CcSEcCtD
Bexarotene—Body temperature increased—Leflunomide—systemic scleroderma	0.000372	0.000402	CcSEcCtD
Bexarotene—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000369	0.000399	CcSEcCtD
Bexarotene—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000369	0.000399	CcSEcCtD
Bexarotene—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000369	0.000399	CcSEcCtD
Bexarotene—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000369	0.000399	CcSEcCtD
Bexarotene—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000369	0.000398	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000368	0.000398	CcSEcCtD
Bexarotene—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000368	0.000398	CcSEcCtD
Bexarotene—Hypersensitivity—Azathioprine—systemic scleroderma	0.000367	0.000396	CcSEcCtD
Bexarotene—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000367	0.000396	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000367	0.000396	CcSEcCtD
Bexarotene—Insomnia—Lisinopril—systemic scleroderma	0.000365	0.000395	CcSEcCtD
Bexarotene—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000365	0.000394	CcSEcCtD
Bexarotene—Paraesthesia—Lisinopril—systemic scleroderma	0.000363	0.000392	CcSEcCtD
Bexarotene—Vomiting—Captopril—systemic scleroderma	0.000363	0.000392	CcSEcCtD
Bexarotene—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000361	0.00039	CcSEcCtD
Bexarotene—Dyspnoea—Lisinopril—systemic scleroderma	0.00036	0.000389	CcSEcCtD
Bexarotene—Rash—Captopril—systemic scleroderma	0.00036	0.000389	CcSEcCtD
Bexarotene—Dermatitis—Captopril—systemic scleroderma	0.000359	0.000388	CcSEcCtD
Bexarotene—Somnolence—Lisinopril—systemic scleroderma	0.000359	0.000388	CcSEcCtD
Bexarotene—Headache—Captopril—systemic scleroderma	0.000357	0.000386	CcSEcCtD
Bexarotene—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000357	0.000386	CcSEcCtD
Bexarotene—Dyspepsia—Lisinopril—systemic scleroderma	0.000355	0.000384	CcSEcCtD
Bexarotene—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000354	0.000383	CcSEcCtD
Bexarotene—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000354	0.000383	CcSEcCtD
Bexarotene—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000354	0.000382	CcSEcCtD
Bexarotene—Infection—Mycophenolate mofetil—systemic scleroderma	0.000352	0.00038	CcSEcCtD
Bexarotene—Decreased appetite—Lisinopril—systemic scleroderma	0.000351	0.000379	CcSEcCtD
Bexarotene—Eosinophilia—Methotrexate—systemic scleroderma	0.000349	0.000377	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000349	0.000377	CcSEcCtD
Bexarotene—Fatigue—Lisinopril—systemic scleroderma	0.000348	0.000376	CcSEcCtD
Bexarotene—Shock—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000376	CcSEcCtD
Bexarotene—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000347	0.000375	CcSEcCtD
Bexarotene—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000346	0.000374	CcSEcCtD
Bexarotene—Hypersensitivity—Leflunomide—systemic scleroderma	0.000346	0.000374	CcSEcCtD
Bexarotene—Pancreatitis—Methotrexate—systemic scleroderma	0.000346	0.000374	CcSEcCtD
Bexarotene—Constipation—Lisinopril—systemic scleroderma	0.000345	0.000373	CcSEcCtD
Bexarotene—Pain—Lisinopril—systemic scleroderma	0.000345	0.000373	CcSEcCtD
Bexarotene—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000345	0.000373	CcSEcCtD
Bexarotene—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000344	0.000371	CcSEcCtD
Bexarotene—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000342	0.00037	CcSEcCtD
Bexarotene—Diarrhoea—Azathioprine—systemic scleroderma	0.000341	0.000368	CcSEcCtD
Bexarotene—Haemoglobin—Prednisone—systemic scleroderma	0.000339	0.000367	CcSEcCtD
Bexarotene—Nausea—Captopril—systemic scleroderma	0.000339	0.000366	CcSEcCtD
Bexarotene—Haemorrhage—Prednisone—systemic scleroderma	0.000338	0.000365	CcSEcCtD
Bexarotene—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000337	0.000365	CcSEcCtD
Bexarotene—Asthenia—Leflunomide—systemic scleroderma	0.000337	0.000364	CcSEcCtD
Bexarotene—Pancytopenia—Methotrexate—systemic scleroderma	0.000335	0.000362	CcSEcCtD
Bexarotene—Feeling abnormal—Lisinopril—systemic scleroderma	0.000333	0.00036	CcSEcCtD
Bexarotene—Pruritus—Leflunomide—systemic scleroderma	0.000333	0.000359	CcSEcCtD
Bexarotene—Connective tissue disorder—Prednisone—systemic scleroderma	0.000332	0.000359	CcSEcCtD
Bexarotene—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00033	0.000357	CcSEcCtD
Bexarotene—Dysuria—Methotrexate—systemic scleroderma	0.00033	0.000356	CcSEcCtD
Bexarotene—Neutropenia—Methotrexate—systemic scleroderma	0.00033	0.000356	CcSEcCtD
Bexarotene—Dizziness—Azathioprine—systemic scleroderma	0.000329	0.000356	CcSEcCtD
Bexarotene—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000325	0.000351	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000348	CcSEcCtD
Bexarotene—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000322	0.000348	CcSEcCtD
Bexarotene—Asthenia—Mycophenolic acid—systemic scleroderma	0.000322	0.000348	CcSEcCtD
Bexarotene—Diarrhoea—Leflunomide—systemic scleroderma	0.000322	0.000348	CcSEcCtD
Bexarotene—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00032	0.000346	CcSEcCtD
Bexarotene—Body temperature increased—Lisinopril—systemic scleroderma	0.000319	0.000345	CcSEcCtD
Bexarotene—Abdominal pain—Lisinopril—systemic scleroderma	0.000319	0.000345	CcSEcCtD
Bexarotene—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.000343	CcSEcCtD
Bexarotene—Pruritus—Mycophenolic acid—systemic scleroderma	0.000317	0.000343	CcSEcCtD
Bexarotene—Vomiting—Azathioprine—systemic scleroderma	0.000316	0.000342	CcSEcCtD
Bexarotene—Pneumonia—Methotrexate—systemic scleroderma	0.000316	0.000342	CcSEcCtD
Bexarotene—Eye disorder—Prednisone—systemic scleroderma	0.000315	0.000341	CcSEcCtD
Bexarotene—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000341	CcSEcCtD
Bexarotene—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000315	0.00034	CcSEcCtD
Bexarotene—Rash—Azathioprine—systemic scleroderma	0.000314	0.000339	CcSEcCtD
Bexarotene—Dermatitis—Azathioprine—systemic scleroderma	0.000313	0.000339	CcSEcCtD
Bexarotene—Headache—Azathioprine—systemic scleroderma	0.000312	0.000337	CcSEcCtD
Bexarotene—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000311	0.000337	CcSEcCtD
Bexarotene—Dizziness—Leflunomide—systemic scleroderma	0.000311	0.000336	CcSEcCtD
Bexarotene—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000308	0.000332	CcSEcCtD
Bexarotene—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000307	0.000332	CcSEcCtD
Bexarotene—Stomatitis—Methotrexate—systemic scleroderma	0.000306	0.000331	CcSEcCtD
Bexarotene—Angiopathy—Prednisone—systemic scleroderma	0.000306	0.000331	CcSEcCtD
Bexarotene—Conjunctivitis—Methotrexate—systemic scleroderma	0.000305	0.00033	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000305	0.00033	CcSEcCtD
Bexarotene—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000327	CcSEcCtD
Bexarotene—Pain—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000327	CcSEcCtD
Bexarotene—Arrhythmia—Prednisone—systemic scleroderma	0.000302	0.000326	CcSEcCtD
Bexarotene—Sweating—Methotrexate—systemic scleroderma	0.000301	0.000326	CcSEcCtD
Bexarotene—Haematuria—Methotrexate—systemic scleroderma	0.0003	0.000324	CcSEcCtD
Bexarotene—Vomiting—Leflunomide—systemic scleroderma	0.000299	0.000323	CcSEcCtD
Bexarotene—Alopecia—Prednisone—systemic scleroderma	0.000298	0.000322	CcSEcCtD
Bexarotene—Hypersensitivity—Lisinopril—systemic scleroderma	0.000298	0.000322	CcSEcCtD
Bexarotene—Dizziness—Mycophenolic acid—systemic scleroderma	0.000296	0.00032	CcSEcCtD
Bexarotene—Epistaxis—Methotrexate—systemic scleroderma	0.000296	0.00032	CcSEcCtD
Bexarotene—Rash—Leflunomide—systemic scleroderma	0.000296	0.00032	CcSEcCtD
Bexarotene—Dermatitis—Leflunomide—systemic scleroderma	0.000296	0.00032	CcSEcCtD
Bexarotene—Nausea—Azathioprine—systemic scleroderma	0.000296	0.00032	CcSEcCtD
Bexarotene—Headache—Leflunomide—systemic scleroderma	0.000294	0.000318	CcSEcCtD
Bexarotene—Erythema—Prednisone—systemic scleroderma	0.000294	0.000318	CcSEcCtD
Bexarotene—Malnutrition—Prednisone—systemic scleroderma	0.000294	0.000318	CcSEcCtD
Bexarotene—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000315	CcSEcCtD
Bexarotene—Asthenia—Lisinopril—systemic scleroderma	0.00029	0.000313	CcSEcCtD
Bexarotene—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000313	CcSEcCtD
Bexarotene—Pruritus—Lisinopril—systemic scleroderma	0.000286	0.000309	CcSEcCtD
Bexarotene—Vomiting—Mycophenolic acid—systemic scleroderma	0.000285	0.000308	CcSEcCtD
Bexarotene—Haemoglobin—Methotrexate—systemic scleroderma	0.000284	0.000306	CcSEcCtD
Bexarotene—Rash—Mycophenolic acid—systemic scleroderma	0.000283	0.000306	CcSEcCtD
Bexarotene—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000282	0.000305	CcSEcCtD
Bexarotene—Haemorrhage—Methotrexate—systemic scleroderma	0.000282	0.000305	CcSEcCtD
Bexarotene—Headache—Mycophenolic acid—systemic scleroderma	0.000281	0.000304	CcSEcCtD
Bexarotene—Pharyngitis—Methotrexate—systemic scleroderma	0.00028	0.000303	CcSEcCtD
Bexarotene—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000302	CcSEcCtD
Bexarotene—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00028	0.000302	CcSEcCtD
Bexarotene—Nausea—Leflunomide—systemic scleroderma	0.000279	0.000302	CcSEcCtD
Bexarotene—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000279	0.000301	CcSEcCtD
Bexarotene—Urethral disorder—Methotrexate—systemic scleroderma	0.000277	0.000299	CcSEcCtD
Bexarotene—Diarrhoea—Lisinopril—systemic scleroderma	0.000276	0.000299	CcSEcCtD
Bexarotene—Ill-defined disorder—Prednisone—systemic scleroderma	0.000273	0.000295	CcSEcCtD
Bexarotene—Anaemia—Prednisone—systemic scleroderma	0.000272	0.000294	CcSEcCtD
Bexarotene—Agitation—Prednisone—systemic scleroderma	0.00027	0.000292	CcSEcCtD
Bexarotene—Dizziness—Lisinopril—systemic scleroderma	0.000267	0.000289	CcSEcCtD
Bexarotene—Nausea—Mycophenolic acid—systemic scleroderma	0.000266	0.000288	CcSEcCtD
Bexarotene—Malaise—Prednisone—systemic scleroderma	0.000265	0.000286	CcSEcCtD
Bexarotene—Vertigo—Prednisone—systemic scleroderma	0.000264	0.000285	CcSEcCtD
Bexarotene—Eye disorder—Methotrexate—systemic scleroderma	0.000264	0.000285	CcSEcCtD
Bexarotene—Syncope—Prednisone—systemic scleroderma	0.000264	0.000285	CcSEcCtD
Bexarotene—Tinnitus—Methotrexate—systemic scleroderma	0.000263	0.000284	CcSEcCtD
Bexarotene—Cardiac disorder—Methotrexate—systemic scleroderma	0.000262	0.000283	CcSEcCtD
Bexarotene—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000282	CcSEcCtD
Bexarotene—Loss of consciousness—Prednisone—systemic scleroderma	0.000258	0.000279	CcSEcCtD
Bexarotene—Vomiting—Lisinopril—systemic scleroderma	0.000257	0.000278	CcSEcCtD
Bexarotene—Angiopathy—Methotrexate—systemic scleroderma	0.000256	0.000277	CcSEcCtD
Bexarotene—Rash—Lisinopril—systemic scleroderma	0.000255	0.000275	CcSEcCtD
Bexarotene—Dermatitis—Lisinopril—systemic scleroderma	0.000254	0.000275	CcSEcCtD
Bexarotene—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.000274	CcSEcCtD
Bexarotene—Hypertension—Prednisone—systemic scleroderma	0.000254	0.000274	CcSEcCtD
Bexarotene—Chills—Methotrexate—systemic scleroderma	0.000253	0.000274	CcSEcCtD
Bexarotene—Headache—Lisinopril—systemic scleroderma	0.000253	0.000273	CcSEcCtD
Bexarotene—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00025	0.000271	CcSEcCtD
Bexarotene—Myalgia—Prednisone—systemic scleroderma	0.00025	0.00027	CcSEcCtD
Bexarotene—Arthralgia—Prednisone—systemic scleroderma	0.00025	0.00027	CcSEcCtD
Bexarotene—Anxiety—Prednisone—systemic scleroderma	0.000249	0.000269	CcSEcCtD
Bexarotene—Alopecia—Methotrexate—systemic scleroderma	0.000249	0.000269	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000248	0.000269	CcSEcCtD
Bexarotene—Discomfort—Prednisone—systemic scleroderma	0.000247	0.000267	CcSEcCtD
Bexarotene—Malnutrition—Methotrexate—systemic scleroderma	0.000246	0.000265	CcSEcCtD
Bexarotene—Erythema—Methotrexate—systemic scleroderma	0.000246	0.000265	CcSEcCtD
Bexarotene—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000242	0.000262	CcSEcCtD
Bexarotene—Dysgeusia—Methotrexate—systemic scleroderma	0.000241	0.00026	CcSEcCtD
Bexarotene—Nausea—Lisinopril—systemic scleroderma	0.00024	0.000259	CcSEcCtD
Bexarotene—Oedema—Prednisone—systemic scleroderma	0.00024	0.000259	CcSEcCtD
Bexarotene—Infection—Prednisone—systemic scleroderma	0.000238	0.000258	CcSEcCtD
Bexarotene—Back pain—Methotrexate—systemic scleroderma	0.000238	0.000257	CcSEcCtD
Bexarotene—Shock—Prednisone—systemic scleroderma	0.000236	0.000255	CcSEcCtD
Bexarotene—Nervous system disorder—Prednisone—systemic scleroderma	0.000235	0.000254	CcSEcCtD
Bexarotene—Tachycardia—Prednisone—systemic scleroderma	0.000234	0.000253	CcSEcCtD
Bexarotene—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000253	CcSEcCtD
Bexarotene—Skin disorder—Prednisone—systemic scleroderma	0.000233	0.000252	CcSEcCtD
Bexarotene—Hyperhidrosis—Prednisone—systemic scleroderma	0.000232	0.000251	CcSEcCtD
Bexarotene—Anorexia—Prednisone—systemic scleroderma	0.000229	0.000247	CcSEcCtD
Bexarotene—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000228	0.000246	CcSEcCtD
Bexarotene—Anaemia—Methotrexate—systemic scleroderma	0.000227	0.000245	CcSEcCtD
Bexarotene—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000243	CcSEcCtD
Bexarotene—Rash—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000241	CcSEcCtD
Bexarotene—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000223	0.000241	CcSEcCtD
Bexarotene—Headache—Mycophenolate mofetil—systemic scleroderma	0.000222	0.00024	CcSEcCtD
Bexarotene—Malaise—Methotrexate—systemic scleroderma	0.000221	0.000239	CcSEcCtD
Bexarotene—Vertigo—Methotrexate—systemic scleroderma	0.000221	0.000239	CcSEcCtD
Bexarotene—Leukopenia—Methotrexate—systemic scleroderma	0.00022	0.000238	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000219	0.000236	CcSEcCtD
Bexarotene—Insomnia—Prednisone—systemic scleroderma	0.000217	0.000234	CcSEcCtD
Bexarotene—Paraesthesia—Prednisone—systemic scleroderma	0.000215	0.000233	CcSEcCtD
Bexarotene—Cough—Methotrexate—systemic scleroderma	0.000214	0.000232	CcSEcCtD
Bexarotene—Dyspepsia—Prednisone—systemic scleroderma	0.000211	0.000228	CcSEcCtD
Bexarotene—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000227	CcSEcCtD
Bexarotene—Arthralgia—Methotrexate—systemic scleroderma	0.000209	0.000226	CcSEcCtD
Bexarotene—Chest pain—Methotrexate—systemic scleroderma	0.000209	0.000226	CcSEcCtD
Bexarotene—Myalgia—Methotrexate—systemic scleroderma	0.000209	0.000226	CcSEcCtD
Bexarotene—Decreased appetite—Prednisone—systemic scleroderma	0.000208	0.000225	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000208	0.000224	CcSEcCtD
Bexarotene—Fatigue—Prednisone—systemic scleroderma	0.000207	0.000224	CcSEcCtD
Bexarotene—Discomfort—Methotrexate—systemic scleroderma	0.000207	0.000223	CcSEcCtD
Bexarotene—Constipation—Prednisone—systemic scleroderma	0.000205	0.000222	CcSEcCtD
Bexarotene—Confusional state—Methotrexate—systemic scleroderma	0.000202	0.000218	CcSEcCtD
Bexarotene—Infection—Methotrexate—systemic scleroderma	0.000199	0.000215	CcSEcCtD
Bexarotene—Feeling abnormal—Prednisone—systemic scleroderma	0.000198	0.000214	CcSEcCtD
Bexarotene—Nervous system disorder—Methotrexate—systemic scleroderma	0.000197	0.000212	CcSEcCtD
Bexarotene—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000196	0.000212	CcSEcCtD
Bexarotene—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000196	0.000212	CcSEcCtD
Bexarotene—Skin disorder—Methotrexate—systemic scleroderma	0.000195	0.00021	CcSEcCtD
Bexarotene—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000194	0.000209	CcSEcCtD
Bexarotene—Anorexia—Methotrexate—systemic scleroderma	0.000191	0.000207	CcSEcCtD
Bexarotene—Body temperature increased—Prednisone—systemic scleroderma	0.00019	0.000205	CcSEcCtD
Bexarotene—Abdominal pain—Prednisone—systemic scleroderma	0.00019	0.000205	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000183	0.000197	CcSEcCtD
Bexarotene—Insomnia—Methotrexate—systemic scleroderma	0.000181	0.000196	CcSEcCtD
Bexarotene—Paraesthesia—Methotrexate—systemic scleroderma	0.00018	0.000195	CcSEcCtD
Bexarotene—Dyspnoea—Methotrexate—systemic scleroderma	0.000179	0.000193	CcSEcCtD
Bexarotene—Somnolence—Methotrexate—systemic scleroderma	0.000178	0.000193	CcSEcCtD
Bexarotene—Hypersensitivity—Prednisone—systemic scleroderma	0.000177	0.000191	CcSEcCtD
Bexarotene—Dyspepsia—Methotrexate—systemic scleroderma	0.000176	0.000191	CcSEcCtD
Bexarotene—Decreased appetite—Methotrexate—systemic scleroderma	0.000174	0.000188	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000173	0.000187	CcSEcCtD
Bexarotene—Fatigue—Methotrexate—systemic scleroderma	0.000173	0.000187	CcSEcCtD
Bexarotene—Asthenia—Prednisone—systemic scleroderma	0.000172	0.000186	CcSEcCtD
Bexarotene—Pain—Methotrexate—systemic scleroderma	0.000171	0.000185	CcSEcCtD
Bexarotene—Pruritus—Prednisone—systemic scleroderma	0.00017	0.000183	CcSEcCtD
Bexarotene—Feeling abnormal—Methotrexate—systemic scleroderma	0.000165	0.000179	CcSEcCtD
Bexarotene—Diarrhoea—Prednisone—systemic scleroderma	0.000164	0.000177	CcSEcCtD
Bexarotene—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000164	0.000177	CcSEcCtD
Bexarotene—Dizziness—Prednisone—systemic scleroderma	0.000159	0.000171	CcSEcCtD
Bexarotene—Abdominal pain—Methotrexate—systemic scleroderma	0.000158	0.000171	CcSEcCtD
Bexarotene—Body temperature increased—Methotrexate—systemic scleroderma	0.000158	0.000171	CcSEcCtD
Bexarotene—Vomiting—Prednisone—systemic scleroderma	0.000152	0.000165	CcSEcCtD
Bexarotene—Rash—Prednisone—systemic scleroderma	0.000151	0.000163	CcSEcCtD
Bexarotene—Dermatitis—Prednisone—systemic scleroderma	0.000151	0.000163	CcSEcCtD
Bexarotene—Headache—Prednisone—systemic scleroderma	0.00015	0.000162	CcSEcCtD
Bexarotene—Hypersensitivity—Methotrexate—systemic scleroderma	0.000148	0.00016	CcSEcCtD
Bexarotene—Asthenia—Methotrexate—systemic scleroderma	0.000144	0.000155	CcSEcCtD
Bexarotene—Nausea—Prednisone—systemic scleroderma	0.000142	0.000154	CcSEcCtD
Bexarotene—Pruritus—Methotrexate—systemic scleroderma	0.000142	0.000153	CcSEcCtD
Bexarotene—Diarrhoea—Methotrexate—systemic scleroderma	0.000137	0.000148	CcSEcCtD
Bexarotene—Dizziness—Methotrexate—systemic scleroderma	0.000133	0.000143	CcSEcCtD
Bexarotene—Vomiting—Methotrexate—systemic scleroderma	0.000127	0.000138	CcSEcCtD
Bexarotene—Rash—Methotrexate—systemic scleroderma	0.000126	0.000137	CcSEcCtD
Bexarotene—Dermatitis—Methotrexate—systemic scleroderma	0.000126	0.000136	CcSEcCtD
Bexarotene—Headache—Methotrexate—systemic scleroderma	0.000126	0.000136	CcSEcCtD
Bexarotene—Nausea—Methotrexate—systemic scleroderma	0.000119	0.000129	CcSEcCtD
